Benjamin Albrecht
Emory Healthcare(US)Emory University(US)Emory University Hospital(US)
Publications by Year
Research Areas
Bacterial Identification and Susceptibility Testing, Antimicrobial Resistance in Staphylococcus, Antibiotic Use and Resistance, Streptococcal Infections and Treatments, Clostridium difficile and Clostridium perfringens research
Most-Cited Works
- → Long-term Dalbavancin for Suppression of Gram-Positive Chronic Left Ventricular Assist Device Infections(2023)9 cited
- → A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in Non–Hospital Care Settings in 2021(2022)7 cited
- → Toxin inhibition: Examining tetracyclines, clindamycin, and linezolid(2024)5 cited
- → Evaluation of Sequential Oral Versus Intravenous Antibiotic Treatment of Enterococcus faecalis Bloodstream Infections(2024)5 cited
- → A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022(2024)4 cited
- → Impact of internal medicine pharmacists on antimicrobial stewardship(2024)2 cited
- → Nephrotoxic Risk Associated With Combination Therapy of Vancomycin and Piperacillin-Tazobactam in Critically Ill Patients With Chronic Kidney Disease(2024)2 cited
- → Combating resistant pathogens: exploring the efficacy of eravacycline utilization in multidrug-resistant infections(2025)1 cited
- → 1930. Answering the Call: Inpatient Vaccination for SARS-CoV2 Infection in an Academic Hospital(2022)
- → 1567: ACTUAL VERSUS IDEAL BODY WEIGHT FOR FLUID RESUSCITATION IN SEPTIC PATIENTS(2025)